Mutations in KCNQ1, encoding for Kv7.1, the a-subunit of the I Ks channel, cause long-QT syndrome type 1, potentially predisposing patients to ventricular tachyarrhythmias and sudden cardiac death, in particular, during elevated sympathetic tone. Here, we aim at characterizing the p.Lys557Glu (K557E) Kv7.1 mutation, identified in a Dutch kindred, at baseline and during (mimicked) increased adrenergic tone.
Introduction
The congenital long-QT syndrome (LQTS) is a potentially life-threatening cardiac disorder characterized by an increased QT interval on the electrocardiogram (ECG), reflecting prolonged ventricular repolarization. Patients may have variable symptoms, ranging from mild palpitations to syncope and sudden death due to torsades de pointes (TdP)/ventricular fibrillation. Mutations leading to LQTS have been identified in at least 16 different genes 1 encoding for cardiac ion channels or their interacting proteins.
LQTS type 1 (LQTS1) accounts for 35% of all cases of LQTS and is caused by mutations in the KCNQ1 gene, encoding Kv7.1, the a-subunit of the slowly activating delayed rectifier K + (I Ks ) channel. To date, .250 different KCNQ1 mutations associated with LQTS1 have been reported. While expression of the homotetrameric Kv7.1 channel only elicits a rapidly activating K + current, co-assembly with the modulatory b-subunit minK, encoded by the KCNE1 gene, causes marked slowing of the activation and a strong increase in current amplitude, typical of I Ks . 2, 3 Under basal unstimulated isolated myocyte conditions, I Ks plays a minor role in ventricular repolarization. 4 However, its contribution to the so-called repolarization reserve becomes significant when action potential duration (APD) is prolonged due to a decrease in other repolarizing currents and can be modulated through various regulatory processes, notably b-adrenergic receptor (bAR) stimulation and fast heart rate. 4 -10 These can cause significant up-regulation of I Ks , allowing it to play an important role in the shortening of APD. bAR regulation of I Ks requires 3 ′ -5 ′ -cyclic adenosine monophosphate (cAMP)-dependent activation of protein kinase A (PKA) anchored to the channel by the A-kinase anchoring protein (AKAP) Yotiao. PKA subsequently phosphorylates Serine 27 at the Kv7.1 N-terminus, resulting in a strong current up-regulation. 11, 12 Furthermore, Yotiao plays an important role in the translation of this phosphorylation to enhanced I Ks . 13 -15 The complexity of the I Ks macromolecular complex and the important role of neurohumoral modulation of I Ks in cardiac repolarization make a multilevel approach imperative when determining the cellular and clinical effects of a given KCNQ1 mutation. 16 Here, we report the results of a translational study on the LQTS1 mutation p.K557E, 17 obtained by combining analyses of the ECGs of carriers at rest and during exercise, with a cellular electrophysiological characterization of mutant I Ks and its cAMP-dependent regulation, confocal imaging, and mathematical modelling.
Methods
An extended overview of the Methods is provided in the Supplementary material online. This study conforms to the Declaration of Helsinki and was performed according to a protocol approved by the local ethics committee of Maastricht University Medical Centre, The Netherlands. Patients gave written informed consent for DNA diagnostics and ECG research.
Clinical and genetic diagnosis
LQTS was diagnosed if the heart rate-corrected QT interval (Bazett's equation) exceeded 440 ms in the standard 12-lead ECG at baseline and/or during exercise testing. The latter was performed using a standard Bruce protocol. Pace and inclination were increased every 3 min until exhaustion or for other clinical reasons to halt, followed by a 5-min recovery period. The ECG was monitored constantly.
Patients were genotyped using standard molecular techniques, as previously described. 17 
Site-directed mutagenesis and cell transfection
K557E was generated by site-directed mutagenesis based on wild-type (WT) human KCNQ1 using the QuikChangew II XL kit.
Chinese hamster ovary (CHO) cells were cultured at 378C/5% CO 2 in Ham's F-12 medium supplemented with 10% fetal calf serum and 1% penicillin/streptomycin. For patch-clamp recordings in WT or homozygous mutant (K557E hom ) experiments, KCNQ1 (0.5 mg; WT or mutant) and KCNE1 (1 mg) cDNA were transiently co-transfected in CHO cells using Fugenew 6 (Roche Diagnostics Nederland B.V., Almere, The Netherlands/Promega Benelux B.V., Leiden, The Netherlands). In co-expression studies (examining heterozygous conditions, K557E het ), 0.25 mg WT KCNQ1 and 0.25 mg mutant KCNQ1 were transfected with 1.0 mg KCNE1. In addition, Yotiao (2 mg) was co-transfected in cells employed for patch-clamp recordings. Cells were used for measurements at 20-24 h after transfection.
Electrophysiological experiments
For electrophysiological studies, CHO cells were harvested from the culture dish by a brief trypsinization, washed twice with culture medium, and placed in a perfusion chamber on an inverted microscope that was continuously perfused with an external Tyrode's solution containing the following (in mmol/L): 132 NaCl, 4. EGTA, and 10 HEPES (pH ¼ 7.3 with KOH). To mimic PKA-mediated bAR stimulation, 0.2 mmol/L okadaic acid (OA) and 200 mmol/L cAMP were added to the pipette solution. Experiments were performed using the whole-cell patch-clamp technique at room temperature. Pipette resistance ranged between 1.5 and 3 MV, access resistance was determined to be up to 8 MV, and the series resistance was electronically compensated at 60 -80%. Currents were sampled at 2 kHz after low-pass filtering at 1 kHz. Current density was calculated by dividing current amplitude by cell capacity. The voltage dependence of activation (evaluated from normalized tail current amplitudes) was fitted with a Boltzmann equation, y ¼ I max /(1 + exp((V 1/2 2 V )/k)), to determine the membrane potential for half-maximal activation (midpoint; V 1/2 ) and the slope factor (k). Time courses of activation and deactivation were fitted with a single exponential function, y ¼ A × (1 2 exp(2t/t)), where A is amplitude and t is time constant.
Confocal imaging
WT and mutant Kv7.1 were tagged with green fluorescent protein (GFP) at the Kv7.1 C-terminus. CHO cells were grown on cover slips and transfected using Lipofectaminew LTX (Life Technologies) or Fugenew 6. For transfection, 1 mg of WT KCNQ1-GFP or K557E-GFP cDNA and 2 mg of untagged KCNE1 cDNA were used. For K557E het , either WT KCNQ1-GFP (0.5 mg) combined with untagged K557E (0.5 mg) and KCNE1 (2 mg), or mutant K557E-GFP (0.5 mg) combined with untagged WT KCNQ1 (0.5 mg) and KCNE1 (2 mg) were transfected. Forty-eight hours after transfection, confocal images were obtained on a Leica TCS-SPE confocal microscope and further analysed using LAS AF Lite software v2.2.1.
Computational modelling
Using a detailed computational model of the canine epicardial myocyte 18 (with bAR stimulation incorporated), the effects of K557E on the action potential (AP) configuration were studied. Parameters of bAR-stimulated and -unstimulated WT or K557E het I Ks were based on the experimental data obtained in patch-clamp studies in CHO cells in the absence or presence of cAMP/OA, after correction for temperature. The model subsequently determined the total current in response to bAR stimulation with isoproterenol based on the I Ks phosphorylation status, as previously described. 15 
Statistical analysis
Results are expressed as mean + SEM from n patients/cells. An unpaired Student's t-test, a one-way analysis of variance, or a two-way analysis of variance with Tukey's post hoc test was used to determine statistical differences when appropriate. A P value , 0.05 was considered statistically significant.
Results

Genetic and clinical characterization
An A to G point mutation at nucleotide position c.1669 of the KCNQ1 gene (NCBI reference sequence NM_000218.2), causing a change from lysine to glutamic acid at protein position 557 (p.K557E) in the coiled-coil domain of the channel, was identified in the proband and various members of a Dutch family (Figure 1 ). Non-paternity was excluded for the proband. The mutation had occurred de novo. Baseline QTc averaged 476 + 13 ms in K557E carriers (n ¼ 8, age: 22 + 7 years) vs. 400 + 9 ms in unaffected siblings (P , 0.05; n ¼ 5, age: 32 + 15 years). During treadmill exercise testing, the QTc interval of mutation carriers (age: 37 + 10 years) prolonged by 91 + 11 ms ( 19%) at peak exercise (from 474 + 11 ms at rest to 564 + 12 ms, n ¼ 5, P , 0.005). After 1 and 2 min of recovery, QTc prolonged further to 604 + 21 and 598 + 15 ms, respectively, all P , 0.005 vs. their corresponding QTc at rest, unlike the findings in an unaffected family Characteristics of the LQTS1 mutation p.K557E-Kv7.1 member (subject III:3, age: 27 years) in whom QTc was 389 + 6, 382 + 1, 418 + 8, and 425 + 8 ms for rest, peak exercise, 1-min, and 2-min recovery, respectively ( Figure 2A ). These control values are consistent with reports in the literature.
19 Figure 2B and C show representative
ECGs and QTc and RR findings in a K557E mutation carrier, in whom QTc prolonged by 34 + 2% after 1-min recovery from exercise (subject IV:1). Symptomatic carriers (n ¼ 3 of eight family members) experienced palpitations and/or spells, but none had syncope or sudden cardiac death.
Subcellular localization of WT and mutant channel complexes
To determine the effect of K557E on the membrane expression of the mutant I Ks channel, confocal microscopy of CHO cells expressing C-terminally GFP-tagged Kv7.1-WT or Kv7.1-K557E subunits in combination with untagged minK subunits was performed. As depicted in Figure 3A , Kv7.1-WT-GFP/minK and Kv7.1-K557E-GFP/minK channels, as well as their co-expression in heterozygous conditions (K557E het ), showed clear membrane localization. Intensity plots confirmed membrane expression for all groups ( Figure 3B ). Moreover, western blot experiments showed no differences in Kv7.1 expression in lysates or membrane fractions, and no difference in Kv7.1 lysate-to-membrane ratio of CHO cells from WT, K557 het , or K557E hom groups ( Figure 3C ). Together, these data indicate that K557E did not disturb processing and trafficking of the mutant channel protein.
Biophysical properties of WT and K557E-mutant I Ks channel complexes
A slowly activating K + current was elicited during a 5-s depolarizing pulse from 280 to +60 mV by the WT I Ks channel complex expressed in CHO cells ( Figure 4A , '-cAMP/OA'). The mutant current was significantly down-regulated for both K557E het and K557E hom . Key differences between WT, K557E het , and K557E hom are summarized in Table 1 .
To determine the voltage dependence of activation, I Ks tail densities at 240 mV were plotted as a function of the prepulse potential during 5-s depolarizing pulses between 250 and +90 mV for WT, K557E het , and K557E hom ( Figure 4C ). In the WT I Ks channel complex, the activation threshold was approximately 220 mV. K557E het , and particularly K557E hom , showed a rightward shift of the activation curve (see Supplementary material online, Figure S1 ). The slope factors were comparable for WT and K557E hom but significantly increased for K557E het ( Table 1) . Quantitative analysis of a conceptual model of the I Ks channel population suggested that the increase in slope factor for K557E het results from a variable combination of WT and mutant subunits, with some channels opening at more negative potentials than others (see Supplementary material online, Figure S2 ).
Where comparison with WT was possible, the activation kinetics (t act ) of K557E hom were slower, whereas deactivation kinetics (t deact ) were significantly accelerated for all membrane voltages (V m ) ( Figure 4D ). For K557E het , t deact was intermediate to that of WT and K557E hom and was significantly accelerated vs. WT (P , 0.05 for V m more negative than 260 mV). In contrast, t act was significantly slower for all V m where comparison with WT was possible (P , 0.05). Figure 4A ('+cAMP/OA') shows also the averaged current traces during a 5-s depolarizing pulse from 280 to +60 mV after stimulation with cAMP/OA, for WT, K557E het , and K557E hom I Ks channels. The relative change in I Ks tail amplitude for the different variants (normalized to the value after 1 min of wash-in of OA and cAMP 15 ) is shown in Figure 4B . In all, a significant increase in tail current was observed upon cAMP/OA-dependent stimulation. WT I Ks did not increase when the wash-in protocol was performed without cAMP/OA in the pipette. As an additional negative control, Kv7.1 mutant G589D was tested since this mutation has previously been shown to prevent binding of Yotiao 11 and subsequent cAMP-dependent up-regulation when expressed heterozygously. 15 Indeed, G589D het mutant I Ks did not increase when stimulated with cAMP/OA ( Figure 4B ). The steady-state effect of cAMP-dependent stimulation on the current-voltage relationship of the different channels was determined after a 5-min wash-in period ( Figure 4C ). cAMP-dependent stimulation resulted in increased WT, K557E het , and K557E hom I Ks . However, the stimulatory effect of cAMP/OA could not compensate for the reduction in the basal current density caused by the K557E mutation in either heterozygous or homozygous conditions. Furthermore, cAMP-dependent stimulation of the I Ks channel has been reported to result in several gating alterations, including a significant leftward shift of the voltage dependence of activation. 20, 21 This effect was indeed observed for WT and K557E hom . For K557E het , V 1/2 was unchanged (39 + 2 mV). Slope factors for WT, K557E het , and average age: 12 years). (B) Lead II ECG at various time points during rest, peak exercise, and recovery of an exercise test in a 13-year-old female patient carrying K557E (subject IV:1 of pedigree). (C) RR and QTc times at rest (lying and standing) and at every min during exercise test (ex.1-ex.4) of subject IV:1. QT times were corrected for heart rate using both Bazett's (open bars) and Fridericia's (filled bars) formulas. Note the lack of QTc shortening during recovery. Arrow indicates baseline value, vertical grey line represents peak exercise, and hatched horizontal bar represents the period when P waves were imposed on T waves.
cAMP-mediated stimulation of WT and mutant channel complexes
Characteristics of the LQTS1 mutation p.K557E-Kv7.1 K557E hom during cAMP/OA treatment were 14 + 0, 33 + 2, and 15 + 1 ( Table 1 and see Supplementary material online, Figure S1 ). Also during cAMP/OA, t act remained significantly slower for both K557E het and K557E hom compared with WT for overlapping V m ( Figure 4D ). All t deact were significantly accelerated for K557E hom compared with WT. K557E het remained intermediate (P , 0.05 for V m more negative than 260 mV).
Rate-dependent accumulation of K557E-mutant I Ks
In addition to cAMP-dependent up-regulation, I Ks can also be increased through accumulation at rapid stimulation rates. 7 The latter mechanism is determined by the I Ks kinetics. 7, 8 To test the ability of K557E-mutant I Ks to accumulate, we used AP clamp pulses with the interpulse interval set to 20 ms to maximally promote I Ks accumulation. Accumulation of WT I Ks was significantly larger than for K557E het (+841 vs. +208%, isoproterenol AP morphology). In addition, accumulation was significantly more pronounced with the isoproterenol AP waveform compared with the baseline AP morphology ( Table 1 ; Figure 5A and B). When cAMP/OA was added to the pipette solution, these differences were even more pronounced (+2231 vs. +491% compared with Beat 1 for WT and K557E het , isoproterenol AP morphology). Despite functional accumulation in K557E het , the final I Ks density after 100 pulses did not reach the level of WT I Ks . The dependence of I Ks accumulation on interpulse interval was further investigated using square voltage-clamp pulses to +20 mV (see Supplementary material online, Figure S3 ). Consistent with the results with AP clamp pulses, there was a significant accumulation of WT I Ks at short interpulse intervals. K557E het also showed accumulation, but to a much lesser extent. Of note, for both WT and In agreement with the confocal microscopy, we found no difference in the overall Kv7.1 expression, Kv7.1 membrane expression, or membrane-to-total Kv7.1 ratio between WT and K557E mutant channels.
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Figure 4
Baseline electrophysiological characteristics of WT, K557E het , and K557E hom I Ks channels. (A) Averaged current density traces for WT, K557E het , and K557E hom in the absence (2; n ¼ 13, 16, and 9 cells, respectively) or presence (+; n ¼ 15, 11, and 9 cells, respectively) of intrapipette cAMP/OA during a 5-s depolarizing pulse to +60 mV (holding potential was 280 mV in all experiments). Inset: zoom on the tail current densities at baseline. (B) Relative tail current change for WT (n ¼ 15 cells), K557E het (n ¼ 9 cells), K557E hom (n ¼ 9 cells), and G589D het (n ¼ 6 cells) upon repetitive pulses from 270 to +60 mV (in the case of K557E hom , pulses to +90 mV were used) with cAMP/OA in the pipette solution. Values were normalized to the current density obtained after 1-min wash-in of cAMP/OA. After 5 min of wash-in, WT, K557E het , and K557E hom conditions showed a significant increase in tail current density (at t ¼ 5 min; P , 0.05 for all three conditions). G589D het showed no increase on cAMP/OA stimulation. 15 As an additional negative control, WT I Ks without cAMP/OA in the pipette (WT neg.; n ¼ 6) was used. (C) Tail current-voltage relationship for WT, K557E het , and K557E hom after 5-s depolarizing pulses from 250 to +90 mV in absence (left; n ¼ 13, 16, and 7, respectively) and presence (middle; n ¼ 15, 11, and 9, respectively) of cAMP/OA. Voltage protocol is shown at the right side. * indicates significant differences of K557E het and K557E hom vs. WT current. (D) Activation and deactivation kinetics of WT (circles), K557E het (squares), and K557E hom (triangles) channels in absence (left; n act ¼ 13, 5, and 4 cells; n deact ¼ 7, 7, and 8 cells, respectively) and presence (middle; n act ¼ 11, 6, and 4 cells; n deact ¼ 8, 7, and 5 cells, respectively) of cAMP/OA. Time constants derived from monoexponential fits of the raw current traces were plotted as a function of the membrane potential. For the K557E het channel, slowing of the activation and an acceleration of the deactivation kinetics were observed. K557E hom currents were too small in this voltage range to fit the activation kinetics. Voltage protocol is shown at the right side.
Characteristics of the LQTS1 mutation p.K557E-Kv7.1 K557E het I Ks , augmentation generally occurred up to interpulse intervals of 100 ms (see Supplementary material online, Figure S3 ).
Effect of K557E on APD during bAR stimulation
The effect of K557E on ventricular repolarization was additionally investigated using a computational model of bAR stimulation in the canine ventricular myocyte. 18 The non-phosphorylated and phosphorylated populations of I Ks channels in the model reproduced characteristics of WT or K557E het I Ks measured in the absence or presence of cAMP/OA, respectively (see Supplementary material online, Figure  S4 ). K557E het caused a dominant-negative reduction in I Ks amplitude during the AP ( Figure 6A ). ( Figure 6A , left panel; DAPD ¼ 2 ms). In contrast, during bAR stimulation, APD was significantly prolonged in K557E het vs. WT ( Figure 6A , right panel; DAPD ¼ 21 ms). When simulating the in vivo exerciserelated adaptations by applying bAR stimulation and a change in heart rate, APD accommodation was blunted in the presence of K557E ( Figure 6B ), in line with the QTc responses of the tested K557E carriers (Figure 2 ).
Discussion
In this study, we present a comprehensive clinical and cellular characterization of the effects of the C-terminal KCNQ1 mutation p.K557E. In family members with this mutation, basal QTc was moderately prolonged and QT accommodation during exercise testing blunted, in fact leading to augmented QTc prolongation. No major cardiac events were noted, indicating a mild clinical phenotype.
K557E-induced alterations in basal I Ks
The p.K557E mutation is located in the distal C-terminus of Kv7.1, a region that has been implicated in channel assembly, trafficking, and regulation of the macromolecular channel complex. 11, 22, 23 Despite being located in this region, p.K557E does not impair trafficking of I Ks channels to the membrane (Figure 3) . Accumulation of K557E-mutant current at fast rates was partly preserved and cAMP-dependent up-regulation was intact (Figures 4 and 5 ), but these processes could not overcome the severe gating alterations caused by K557E, including a positive shift of the voltage dependence of activation, deceleration of the activation, and acceleration of the deactivation (Figure 4) . The pronounced shift of the voltage dependence of activation (.100 mV) by K557E hom ( Table 1 , see also Supplementary material online, Figure S1 ) is particularly striking since this mutation is located distant from the S4-voltage sensor of Kv7.1. This may suggest that the conformation of the Kv7.1 C-terminus after the change of charge at amino-acid position 557 (from positive to negative) can modulate the voltage sensor or the activation gate. Although homology models of the structure of the Kv7.1 transmembrane region have been described, no structural model is currently available for the Kv7.1 C-terminus. Even in heterozygous conditions mimicking clinical K557E carriership, an 82% reduction in current density at +60 mV was found compared with WT I Ks , indicating that K557E subunits suppress WT Kv7.1-subunit function in a dominant-negative manner. The exact mechanism of this remains unclear. Previous work has suggested that the Kv7.1 distal C-terminus may be involved in channel regulation by phosphatidylinositol 4,5-bisphosphate (PIP2). 24 A similar phenotype, involving a rightward shift in voltage dependence of activation, strongly reduced I Ks and preserved cAMP-dependent stimulation, was seen in Xenopus oocytes homozygously expressing the p.R555C Kv7.1 mutant. This Kv7.1-R555C was shown to have weaker apparent affinity for PIP2. 24, 25 Thus, impaired PIP2 regulation could also contribute to the loss of function of Kv7.1-K557E.
Role of bAR stimulation in K557E carriers
A leucine zipper motif in the C-terminus of Kv7.1 has been shown to be involved in the binding of the AKAP Yotiao and subsequent Yotiaomodulated PKA-dependent regulation of the channel. 11 To investigate the effect of the K557E mutation on this regulation, we performed patchclamp experiments with cAMP and OA in the pipette solution. 11, 12 Significant I Ks up-regulation was observed for WT, K557E het , and K557E hom , indicating that the K557E mutation did not disturb cAMP-dependent regulation of the I Ks channel. Despite of this and despite preserved ratedependent accumulation of I Ks , the severely altered baseline current characteristics dominated the loss of function caused by the K557E mutation. Therefore, mutant I Ks is small in the AP-voltage range, both under baseline and bAR-stimulated conditions, resulting in a significant AP prolongation in the latter case, as supported by our mathematical simulations ( Figure 6 ). These findings are in agreement with a decrease in the available repolarization reserve in affected patients. Thus, although cAMP-dependent regulation is not impaired in these carriers, they may still have an increased risk for the development of ventricular tachyarrhythmias during increased sympathetic tone.
Implications of the present findings
Several studies have identified genetic and biophysical characteristics of KCNQ1 mutations that influence their observed clinical severity. For example, decelerated channel activation has been associated with a higher risk for cardiac events. 26 Although also manifest in K557E, clinical severity is mild with this mutation. With regard to location, mutations in the transmembrane, cytoplasmic-loop and pore regions of Kv7.1 predispose to more frequent and more severe cardiac events than those in the N-or C-terminus. 27 -29 Mutations causing a dominant-negative Characteristics of the LQTS1 mutation p.K557E-Kv7.1 reduction of I Ks in heterologous expression systems have been reported to have a more severe phenotype than haploinsufficient Kv7.1 mutations. 27 Balancing these characteristics in the context of our findings on K557E makes it difficult to classify phenotypic severity for this mutation and indicates the importance of advanced cellular electrophysiological examination, as we did. Currently, ,10% of all reported LQTS1 mutations have been investigated electrophysiologically, and an even smaller number has been evaluated under conditions of (mimicked) bAR stimulation. Given the importance of sympathetic stimulation in arrhythmogenesis in LQTS1 patients, 16 baseline biophysical characteristics alone are likely insufficient to determine the complete functional effects of a mutation. The clinical phenotype of patients carrying the p.K557E-Kv7.1 mutation, showing QTc prolongation in response to exercise, is similar to that recently reported by Wu et al. 30 for the p.G269S-Kv7.1 mutation. However, in that study, excessive prolongation of QT intervals on exercise was suggested to be due to blunted cAMP/PKA-dependent I Ks up-regulation. Since cAMP-dependent I Ks up-regulation is preserved in p.K557E carriers, this suggests that various molecular impairments of I Ks can prevent the recruitment of sufficient net repolarizing current during sympathetic stimulation, thereby resulting in inappropriate QT prolongation and an increased risk for ventricular tachyarrhythmias. Additionally, the use of in silico models is one promising approach to support the prediction of the clinical outcome for mutation carriers, 31 but it requires more robust validation over time. The gap between LQTS1 clinical phenotype and experimental characterization could also be bridged using patient-specific induced pluripotent stem cells that are differentiated into cardiac myocytes. 32 Although promising to provide a better link between genotype and phenotype for individual patients, it may be challenging to precisely characterize the mutant behaviour in such derived cardiomyocytes due to the intrinsic heterozygous condition and the influence of other ion channels and genetic modifiers. In this study, we performed a detailed characterization of the biophysical properties of K557E based on experimental recordings in CHO cells and computational modelling, and we show that this approach provides crucial information for a better understanding of the clinical findings.
Limitations
We performed a detailed electrophysiological characterization of p.K557E in Kv7.1 identified in a single Dutch family. We showed differences in baseline QTc between mutation carriers and non-affected family members. Moreover, carriers had abnormal QTc responses during exercise and recovery. Only one non-carrier underwent a full exercise testing protocol, which rendered a detailed statistical comparison between QTc development in carriers and this non-carrier inappropriate. It cannot be excluded that (genetic) factors other than p.K557E-Kv7.1 contribute to the observed LQTS phenotype in this family. The response of WT-and K557E-Kv7.1 to bAR stimulation was evaluated using intracellular cAMP/OA due to the absence of representative endogenous bAR signalling complexes in CHO cells. Differences between I Ks stimulation through bAR and via intracellular cAMP may exist. We employed a computational model of the canine leftventricular epicardial AP 18 to investigate the effects of p.K557E-Kv7.1
on APD. The model shows impaired APD shortening in response to simulated bAR stimulation (based on I Ks measurements in the presence of cAMP/OA), suggesting an important role of normal I Ks for repolarization accommodation during exercise. However, a quantitative comparison with the exercise tests of patients with p.K557E-Kv7.1, who showed QTc prolongation with exercise, is not possible due to species differences (human vs. canine), differences between cellular and in vivo conditions, differences between simulated isoproterenol and in vivo sympathetic stimulation with heterogeneous autonomic innervation, and potentially other genetic and acquired factors that modulate cardiac repolarization. These are beyond the scope of the current modelling efforts.
Conclusions
The K557E mutation causes a dominant-negative loss of function of the I Ks channel, which relates to severe gating disturbances. Trafficking is not affected. The resulting significant reduction of I Ks leads to a reduced repolarization reserve, associated with QTc prolongation in patients, which is most apparent during exercise testing. Intact bAR regulation and partly preserved rate-dependent current accumulation may underlie, at least partly, the relatively mild phenotype of mutation carriers.
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